STRATEC Biomedical AG
Abierto
17.36 1.64
Resumen
Variación precio
24h
Mínimo
16.68
Máximo
17.68
Ingresos | 2.6M -1.7M |
|---|---|
Ventas | -22M 53M |
P/B Media del Sector | 14.63 30.136 |
BPA | -0.357 |
Rentabilidad por dividendo | 3.3 |
Margen de beneficios | -3.206 |
Empleados | 1,395 |
EBITDA | -6.7M 4.1M |
Recomendaciones | Comprar |
|---|---|
Estimación a 12 Meses | +55.9% upside |
Rentabilidad por dividendo Media del Sector | 3.30% 3.27% |
|---|---|
Próximas Ganancias | 14 ago 2026 |
Capitalización Mercado | 6.8M 221M |
|---|---|
Apertura anterior | 15.72 |
Cierre anterior | 17.36 |
STRATEC Biomedical AG Gráfico
Resultados pasados no son un indicador fiable de resultados futuros.
Acerca de STRATEC Biomedical AG
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.
